Literature DB >> 22140376

Unmasking of a Recessive SCARF2 Mutation by a 22q11.12 de novo Deletion in a Patient with Van den Ende-Gupta Syndrome.

M F Bedeschi1, L Colombo, F Mari, K Hofmann, A Rauch, B Gentilin, A Renieri, D Clerici.   

Abstract

Van den Ende-Gupta syndrome (VDEGS) is a congenital condition characterized by craniofacial and skeletal manifestations, specifically blepharophimosis, malar and maxillary hypoplasia, distinctive nose, arachnocamptodactyly, and long slender bones of the hands and feet. To date, only 24 patients have been described. It is generally thought that the syndrome is transmitted by an autosomal recessive mode of inheritance, although evidence for genetic heterogeneity has recently been presented. We report on a girl followed from birth up to 3 years of life with a set of peculiar minor anomalies, arachnocamptodactyly of hands and feet, characteristic of VDEGS in association with a 22q11.12 deletion. Recently, the VDEGS gene was mapped to the DiGeorge syndrome region on 22q11.2, and homozygous mutations in the SCARF2 gene were identified. We now report the first patient with VDEGS due to compound heterozygosity for the common 22q11.2 microdeletion and a hemizygous SCARF2 splice site mutation.

Entities:  

Year:  2011        PMID: 22140376      PMCID: PMC3214947          DOI: 10.1159/000328135

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  17 in total

1.  22q11 deletion syndrome and limb anomalies: report on two Brazilian patients.

Authors:  Nancy Mizue Kokitsu-Nakata; Maria Leine Guion-Almeida; Antonio Richieri-Costa
Journal:  Cleft Palate Craniofac J       Date:  2008-01-30

2.  van den Ende-Gupta syndrome of blepharophimosis, arachnodactyly, and congenital contractures: clinical delineation and recurrence in brothers.

Authors:  Daniela N Schweitzer; Ralph S Lachman; Barry D Pressman; John M Graham
Journal:  Am J Med Genet A       Date:  2003-04-30       Impact factor: 2.802

Review 3.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

4.  Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2.

Authors:  A Rauch; S Zink; C Zweier; C T Thiel; A Koch; R Rauch; J Lascorz; U Hüffmeier; M Weyand; H Singer; M Hofbeck
Journal:  J Med Genet       Date:  2005-04-14       Impact factor: 6.318

5.  Mutations in SCARF2 are responsible for Van Den Ende-Gupta syndrome.

Authors:  Natascia Anastasio; Tawfeg Ben-Omran; Ahmad Teebi; Kevin C H Ha; Emilie Lalonde; Rehab Ali; Mariam Almureikhi; Vazken M Der Kaloustian; Junhui Liu; David S Rosenblatt; Jacek Majewski; Loydie A Jerome-Majewska
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

Review 6.  van den Ende-Gupta syndrome of blepharophimosis, arachnodactyly, and congenital contractures.

Authors:  Dania Guerra; Otto Sanchez; Antonio Richieri-Costa
Journal:  Am J Med Genet A       Date:  2005-08-01       Impact factor: 2.802

7.  Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome.

Authors:  Avishai A Alkalay; Tingwei Guo; Cristina Montagna; M Cristina Digilio; Bruno Dallapiccola; Bruno Marino; Bernice Morrow
Journal:  Am J Med Genet A       Date:  2011-02-18       Impact factor: 2.802

8.  Marden-Walker-like syndrome without psychomotor retardation: report of a Brazilian girl born to consanguineous parents.

Authors:  J J van den Ende; Y van Bever; E S Rodini; A Richieri-Costa
Journal:  Am J Med Genet       Date:  1992-02-15

9.  Ocular findings in children with a microdeletion in chromosome 22q11.2.

Authors:  Ingele Casteels; Patricia Casaer; Marc Gewillig; Ann Swillen; Koenraad Devriendt
Journal:  Eur J Pediatr       Date:  2007-08-18       Impact factor: 3.183

10.  Characterization of the past and current duplication activities in the human 22q11.2 region.

Authors:  Xingyi Guo; Laina Freyer; Bernice Morrow; Deyou Zheng
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

View more
  11 in total

1.  A de novo 1q23.3-q24.2 deletion combined with a GORAB missense mutation causes a distinctive phenotype with cutis laxa.

Authors:  Mohammed Al-Bughaili; Teresa M Neuhann; Ricarda Flöttmann; Stefan Mundlos; Malte Spielmann; Uwe Kornak; Björn Fischer-Zirnsak
Journal:  J Hum Genet       Date:  2016-09-08       Impact factor: 3.172

2.  Whole-exome sequence analysis highlights the role of unmasked recessive mutations in copy number variants with incomplete penetrance.

Authors:  Matthieu Egloff; Lam-Son Nguyen; Karine Siquier-Pernet; Valérie Cormier-Daire; Geneviève Baujat; Tania Attié-Bitach; Christine Bole-Feysot; Patrick Nitschke; Michel Vekemans; Laurence Colleaux; Valérie Malan
Journal:  Eur J Hum Genet       Date:  2018-02-26       Impact factor: 4.246

3.  Scavenger receptor class F member 2 (SCARF2) as a novel therapeutic target in glioblastoma.

Authors:  Chaeyeong Kim; Gyeyeong Kong; Hyunji Lee; Quangdon Tran; Thuy-Trang T Vo; So Hee Kwon; Jisoo Park; Seon-Hwan Kim; Jongsun Park
Journal:  Toxicol Res       Date:  2022-02-25

Review 4.  Mechanisms of Origin, Phenotypic Effects and Diagnostic Implications of Complex Chromosome Rearrangements.

Authors:  Martin Poot; Thomas Haaf
Journal:  Mol Syndromol       Date:  2015-08-15

Review 5.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

6.  Sclerocornea in a patient with van den Ende-Gupta syndrome homozygous for a SCARF2 microdeletion.

Authors:  Michele P Migliavacca; Nara L M Sobreira; Graziela P M Antonialli; Mariana M Oliveira; Maria Isabel S A Melaragno; Ingele Casteels; Thomy de Ravel; Decio Brunoni; David Valle; Ana Beatriz A Perez
Journal:  Am J Med Genet A       Date:  2014-01-29       Impact factor: 2.802

7.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

Review 8.  Molecular genetics of 22q11.2 deletion syndrome.

Authors:  Bernice E Morrow; Donna M McDonald-McGinn; Beverly S Emanuel; Joris R Vermeesch; Peter J Scambler
Journal:  Am J Med Genet A       Date:  2018-10       Impact factor: 2.802

9.  Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS.

Authors:  Donna M McDonald-McGinn; Somayyeh Fahiminiya; Timothée Revil; Beata A Nowakowska; Joshua Suhl; Alice Bailey; Elisabeth Mlynarski; David R Lynch; Albert C Yan; Larissa T Bilaniuk; Kathleen E Sullivan; Stephen T Warren; Beverly S Emanuel; Joris R Vermeesch; Elaine H Zackai; Loydie A Jerome-Majewska
Journal:  J Med Genet       Date:  2012-12-11       Impact factor: 6.318

10.  Deciphering the pathogenic consequences of chromosomal aberrations in human genetic disease.

Authors:  Wigard P Kloosterman; Ron Hochstenbach
Journal:  Mol Cytogenet       Date:  2014-12-19       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.